Literature DB >> 18218064

A multistate model for bivariate interval-censored failure time data.

Richard J Cook1, Leilei Zeng, Ker-Ai Lee.   

Abstract

SUMMARY: Interval-censored life-history data arise when the events of interest are only detectable at periodic assessments. When interest lies in the occurrence of two such events, bivariate-interval censored event time data are obtained. We describe how to fit a four-state Markov model useful for characterizing the association between two interval-censored event times when the assessment times for the two events may be generated by different inspection processes. The approach treats the two events symmetrically and enables one to fit multiplicative intensity models that give estimates of covariate effects as well as relative risks characterizing the association between the two events. An expectation-maximization (EM) algorithm is described for estimation in which the maximization step can be carried out with standard software. The method is illustrated by application to data from a trial of HIV patients where the events are the onset of viral shedding in the blood and urine among individuals infected with cytomegalovirus.

Entities:  

Mesh:

Year:  2008        PMID: 18218064     DOI: 10.1111/j.1541-0420.2007.00978.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  3 in total

1.  Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease.

Authors:  Baojiang Chen; Xiao-Hua Zhou
Journal:  Biom J       Date:  2011-04-14       Impact factor: 2.207

2.  A Correlated Random Effects Model for Non-homogeneous Markov Processes with Nonignorable Missingness.

Authors:  Baojiang Chen; Xiao-Hua Zhou
Journal:  J Multivar Anal       Date:  2013-05       Impact factor: 1.473

3.  Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease.

Authors:  Le Wang; Rebecca A Hubbard; Rod L Walker; Edward B Lee; Eric B Larson; Paul K Crane
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.